首页 | 本学科首页   官方微博 | 高级检索  
     


DNA ploidy study of resected hepatocellular carcinoma in cirrhotic liver
Authors:Joaquin Balsells   Isabel Caragol   Elena Allende   Isabel Diaz   Ramon Charco   Jose-Luis Lazaro   Enrique Murio  Carlos Margarit
Affiliation:aDepartment of Surgery Biochemistry Unit, Hospital General Universitari Vall d'Hebron Universidad Autónoma de Barcelona, Spain;bPathology Department, Hospital General Universitari Vall d'Hebron Universidad Autónoma de Barcelona, Spain
Abstract:Background/Aims: Results of several studies on DNA ploidy as a prognostic indicator in hepatocellular carcinoma are contradictory. The present study analysed the correlations between DNA ploidy of resected hepatocellular carcinoma and tumour characteristics, tumour recurrence, risk factors and survival.Methods: Tumoural DNA ploidy of hepatocellular carcinomas from 37 patients with cirrhosis who underwent curative tumour resection was studied by flow cytometry.Results: A diploid pattern was found in 23 hepatocellular carcinomas (62.2%) and an aneuploid pattern in 14 (37.8%). The tumour recurrence rate did not differ statistically between diploid (69.6%) and aneuploid (50%) hepatocellular carcinomas. The only prognostic variable with significant difference in DNA pattern was the histologic tumour type; the majority of non-trabecular tumours were aneuploid while most trabecular hepatocellular carcinomas had a diploid DNA pattern. Actuarial survival at 1, 2, 3 and 4 years of patients with diploid and aneuploid tumours was 69.6%, 40.6%, 16.2% and 0%, and 69.3%, 59.4%, 49.5% and 32.9%, respectively (log rank p=0.1927).Conclusion: These results indicate that DNA ploidy has no prognostic value in hepatocellular carcinoma.
Keywords:Cirrhosis   DNA ploidy   Flow cytometry   Hepatocellular carcinoma.
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号